IRBO Insider Trading Activity and SEC Form 4 Filings
IRBO insider trading summary
No open-market insider purchases or sales of Ir Biosciences Holdings Inc (IRBO) have been reported on SEC Form 4 in the past 12 months.
Latest IRBO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 29, 2008 | Hal N Siegel | Director | Buy | $4K (60,000 @ $0.06) |
| Feb 27, 2008 | Michael K Wilhelm | Chief Executive Officer | Buy | $855 (15,000 @ $0.06) |
| Feb 27, 2008 | Robert J Hariri | Director | Buy | $15K (250,000 @ $0.06) |
| Feb 27, 2008 | Michael K Wilhelm | Chief Executive Officer | Buy | $855 (15,000 @ $0.06) |
| Feb 27, 2008 | Michael K Wilhelm | Chief Executive Officer | Buy | $855 (15,000 @ $0.06) |
| Nov 6, 2007 | Hal N Siegel | Director | Buy | $6K (50,000 @ $0.11) |
| Nov 6, 2007 | Hal N Siegel | Director | Buy | $6K (50,000 @ $0.11) |
| Oct 17, 2007 | Michael K Wilhelm | Chief Executive Officer | Buy | $1K (10,000 @ $0.14) |
| Oct 17, 2007 | Michael K Wilhelm | Chief Executive Officer | Buy | $650 (5,000 @ $0.13) |
| Oct 17, 2007 | Michael K Wilhelm | Chief Executive Officer | Buy | $650 (5,000 @ $0.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.